KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAssetsCash & EquivalentsCommon EquityCurrent AssetsGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cme (CME) Other Non-Current Liabilities (2016 - 2026)

Cme has reported Other Non-Current Liabilities over the past 18 years, most recently at $733.2 million for Q1 2026.

  • Quarterly Other Non-Current Liabilities rose 1.66% to $733.2 million in Q1 2026 from the year-ago period, while the trailing twelve-month figure was $733.2 million through Mar 2026, up 1.66% year-over-year, with the annual reading at $734.8 million for FY2025, 1.89% up from the prior year.
  • Other Non-Current Liabilities was $733.2 million for Q1 2026 at Cme, roughly flat from $734.8 million in the prior quarter.
  • Over five years, Other Non-Current Liabilities peaked at $903.5 million in Q1 2022 and troughed at $720.2 million in Q2 2025.
  • The 5-year median for Other Non-Current Liabilities is $798.2 million (2023), against an average of $788.9 million.
  • Biggest five-year swings in Other Non-Current Liabilities: decreased 17.55% in 2022 and later increased 1.89% in 2025.
  • Tracing CME's Other Non-Current Liabilities over 5 years: stood at $826.0 million in 2022, then fell by 3.37% to $798.2 million in 2023, then dropped by 9.65% to $721.2 million in 2024, then rose by 1.89% to $734.8 million in 2025, then decreased by 0.22% to $733.2 million in 2026.
  • According to Business Quant data, Other Non-Current Liabilities over the past three periods came in at $733.2 million, $734.8 million, and $725.7 million for Q1 2026, Q4 2025, and Q3 2025 respectively.